MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

If the government wants to expand U.S. manufacturing, it must invest in the already booming vaccine industry. The push to ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

Concurrent with the closing, BioNTech has secured control of CureVac's leadership. Three BioNTech managers have joined the CureVac board to steer the integration process. The objective is to closely ...

MSD declines to exercise option for EVX-B2 developmentEvaxion is now able to out-license EVX-B2 to another partnerEvaxion maintains its strong belief in EVX-B2, which has shown to be protective ...

Oekoboiler Swiss AG, a Swiss manufacturer specializing in energy-efficient heat pump boilers, continues to advance ...

For investors still holding CureVac equity, the path forward is clearly defined. BioNTech has stated its intention to acquire the remaining approximately 13.25% of shares via a mandatory squeeze-out ...

BioNTech SE has successfully concluded its takeover bid for CureVac N.V., marking a significant consolidation within the mRNA ...

Researchers at the Hebrew University of Jerusalem have identified a conserved small RNA molecule that enables bacteriophages ...